U.S. federal trademark · Serial No. 97798471
Medical treatment of solid tumor cancers; including research and development of novel therapies related to autologous T lymphocyte therapies
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.